Sender asks 'Have you heard of this colestrol' and forwards a Forbes article about a new drug called Praluent.
This document is an email from Sultan Bin Sulayem to Jeffrey Epstein dated July 24, 2015. Sulayem forwards a Forbes article regarding the FDA approval of a new cholesterol-lowering drug called Praluent (by Regeneron Pharmaceuticals) and asks Epstein if he has heard of it. The document bears a House Oversight Bates stamp.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein communication